Lymphedema of the arm secondary to breast cancer treatment Circulatory System Lymphoedema, not elsewhere classified
Conditions
Interventions
Lymphnodetransfer as a complement to scar release and free flap (DIEP) reconstruction of the breast
Patients with lymphedema referred to the clinic are informed of the present study. If they give the
Sponsors
Uppsala University Hospital
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Patients eligible to breast reconstruction with a DIEP and concomitant lymphedema of the arm
Exclusion criteria
Exclusion criteria: Same criteria as for the DIEP reconstruction
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measured at baseline (preoperatively), 3, 6 and 12 months: 1. Volume of the extremity, measured using water displacement test, 3D camera, tape measurement 2. Patient satisfaction, measured using LyQli and ICL- lymph questionnaire There will also be a long term follow-up at 24 months (not included in the study endpoint) | — |
Secondary
| Measure | Time frame |
|---|---|
| Lymph flow, measured using magnetic resonant imaging and scintigraphy at baseline (preoperatively), 3, 6 and 12 months There will also be a long term follow-up at 24 months (not included in the study endpoint) | — |
Countries
Netherlands, Sweden
Contacts
Public ContactÅsa Wiberg
Outcome results
None listed